Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Rogge

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Pharmaceutical Sciences|July 1, 1984
Bioavailability of hydrocortisone from commercial 20-mg tabletsR B Patel, M C Rogge, A Selen, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjectsS C Chien, A T Chow, J Natarajan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeysJ V Gobburu, C Tenhoor, M C Rogge, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay proceduresP G Welling, A Selen, J G Pearson, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesS C Chien, M C Rogge, L G Gisclon, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Pharmaceutical Sciences|July 1, 1984
Bioavailability of hydrocortisone from commercial 20-mg tabletsR B Patel, M C Rogge, A Selen, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjectsS C Chien, A T Chow, J Natarajan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeysJ V Gobburu, C Tenhoor, M C Rogge, et al.
Biopharmaceutics & Drug Disposition|April 1, 1985
A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay proceduresP G Welling, A Selen, J G Pearson, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesS C Chien, M C Rogge, L G Gisclon, et al.
Pageof 3